Glaxosmithkline Pharmaceuticals has informed that in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Companys shares is closed from Monday, 1st October, 2018 and shall reopen on Thursday, 25th October, 2018, after the approval and declaration of Un-Audited Financial Results for the quarter and half year ended 30th September, 2018, by the Board of Directors at its meeting scheduled to be held on 22nd October, 2018.
The above information is a part of company’s filings submitted to BSE.
